Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Med Eng Phys ; 31(7): 799-805, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19375374

ABSTRACT

Clinical and experimental studies indicate that structural and functional changes in the microvasculature can predate or accompany risk factors for cardiovascular disease at the earliest stages in the disease process. In the current work, both simulated and actual Doppler ultrasound maximum blood velocity waveform envelopes recorded from the ophthalmic artery were analysed using a root-MUSIC and least squares fitting approach to determine amplitude frequency spectra. Both amplitude and frequency components of noise contaminated simulated waveforms were reliably determined indicating the robustness of the technique. The technique was then used to compare the spectral content of the ophthalmic artery blood velocity waveforms of normal controls in three test states: at baseline, following administration of GTN, a nitric oxide donor, and following administration of L-Name, a nitric oxide inhibitor. Principal components derived from root-MUSIC analysis discriminated between waveforms in baseline and non-baseline test states (p<0.00001) and between GTN and non-GTN test states (p=0.0002).


Subject(s)
Nitric Oxide/metabolism , Ophthalmic Artery/drug effects , Ophthalmic Artery/physiology , Signal Processing, Computer-Assisted , Adolescent , Adult , Blood Flow Velocity/drug effects , Humans , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide/agonists , Nitric Oxide/antagonists & inhibitors , Nitric Oxide Donors/pharmacology , Ophthalmic Artery/diagnostic imaging , Ultrasonics , Ultrasonography , Young Adult
2.
Kidney Int ; 70(9): 1636-41, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16955108

ABSTRACT

The link between obesity and renal disease is unclear, and there is no consensus as to whether obese individuals are at increased risk for kidney disease after living kidney donation if they otherwise meet acceptance criteria. We retrospectively studied time-zero (implantation) biopsies in 49 obese (body mass index (BMI) > or = 30 kg/m2) and 41 non-obese (BMI < 30 kg/m2) renal donors that met acceptance criteria. We found that our obese donor population had higher systolic blood pressure (P < 0.001 vs non-obese) and higher absolute iothalamate clearance (P = 0.001 vs non-obese) before donation. The obese donors had larger glomerular planar surface area compared to non-obese controls (P = 0.017), and this parameter correlated with patient weight and urinary microalbumin excretion. Detailed examination of the biopsies revealed that although most histologic findings were similar between groups, the obese donors had more tubular dilation (P = 0.01), but less tubular vacuolization (P = 0.02) than the non-obese controls. There was also a trend toward more arterial hyalinosis in the obese patients than controls (P = 0.08). From these data, our studies detected subtle differences in donor organs obtained from obese compared to non-obese individuals. Further studies should be carried out to quantify the long-term impact of these findings.


Subject(s)
Kidney Glomerulus/cytology , Kidney Glomerulus/pathology , Living Donors , Obesity/pathology , Adult , Aged , Biopsy , Body Mass Index , Female , Follow-Up Studies , Glomerular Filtration Rate/physiology , Humans , Kidney Glomerulus/physiology , Kidney Transplantation/pathology , Male , Middle Aged , Nephrectomy/adverse effects , Obesity/physiopathology , Organ Size , Postoperative Complications/prevention & control , Retrospective Studies
3.
Am J Transplant ; 6(8): 1841-7, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16780546

ABSTRACT

Recent protocols have allowed successful positive crossmatch (+XM) and ABO incompatible (ABOI) kidney transplantation, although their long-term outcome is not clear. To begin to assess this issue we compared protocol biopsies performed 12 months posttransplant in 37 +XM, 24 ABOI and 198 conventional allografts. Although the majority in all three groups had only minimal histologic changes, transplant glomerulopathy (TG) was significantly increased in +XM (22% vs. 13% ABOI vs. 8% conventional, p = 0.015), and correlated with prior humoral rejection (HR) by multivariate analysis (odds ratio 17.5, p < or = 0.0001). Patients with a prior history of HR also had a significant increase in interstitial fibrosis (No HR 54% vs. HR 86%, p = 0.045). In the absence of HR no difference in histologic changes was seen between groups, although all three groups had a demonstrable mild increase in interstitial fibrosis from biopsies performed at the time of transplant. Thus, although HR is associated with an increase in TG, in its absence allograft histology is similar in +XM, ABOI and conventional allografts 1 year posttransplant.


Subject(s)
ABO Blood-Group System/immunology , Blood Group Incompatibility/immunology , Blood Group Incompatibility/pathology , Kidney Transplantation/immunology , Kidney Transplantation/pathology , Living Donors , ABO Blood-Group System/metabolism , Biopsy , Blood Group Incompatibility/metabolism , Complement C4/metabolism , Female , Follow-Up Studies , Graft Rejection , Graft Survival , Humans , Male , Middle Aged , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...